(Q39719946)

14 September 2017

title

Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration (English)

1 reference

14 September 2017

author name string

Alejandro Oliver-Fernandez

1

1 reference

14 September 2017

Jeff Bakal

2

1 reference

14 September 2017

Shaun Segal

3

1 reference

14 September 2017

Gaurav K Shah

4

1 reference

14 September 2017

Ashish Dugar

5

1 reference

14 September 2017

Sanjay Sharma

6

1 reference

14 September 2017

publication date

1 June 2005

1 reference

Canadian Journal of Ophthalmology

14 September 2017

published in

1 reference

14 September 2017

volume

40

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

313-319

1 reference

Risk factors for age-related macular degeneration: Pooled findings from three continents.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Assessment of vision-related function in patients with age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Responsiveness of the SF-36 health survey to changes in visual acuity among patients with subfoveal choroidal neovascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Converting visual acuity to utilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Utility values and age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Growth features of choroidal neovascular membranes in age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Growth rate of subretinal neovascularization in age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Pegaptanib for neovascular age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Waiting times for eye surgery at a Toronto teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-4182%2805%2980074-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-4182(05)80074-2

1 reference

14 September 2017

1 reference